Phase II study of eribulin and pembrolizumab in patients (pts) with metastatic soft tissue sarcomas (STS): Report of LMS cohort.

被引：1
|
作者：
Nathenson, Michael
Choy, Edwin
Carr, Neena D.
Hibbard, Hayley D.
Mazzola, Emanuele
Catalano, Paul J.
Thornton, Katherine Anne
Morgan, Jeffrey A.
Cote, Gregory Michael
Merriam, Priscilla
Wagner, Andrew J.
Demetri, George D.
George, Suzanne
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Med Sch, Ludwig Ctr, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Concord, MA USA
[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11559
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II study of eribulin mesylate in patients (pts) with advanced soft tissue sarcoma (STS).
    Naito, Yoichi
    Kawai, Akira
    Araki, Nobuhito
    Ozaki, Toshifumi
    Sugiura, Hideshi
    Yazawa, Yasuo
    Morioka, Hideo
    Matsumine, Akihiko
    Hiraiwa, Masahide
    Asami, Shun
    Isu, Kazuo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
    Haddox, Candace L.
    Nathenson, Michael J.
    Mazzola, Emanuele
    Lin, Jia-Ren
    Baginska, Joanna
    Nau, Allison
    Weirather, Jason L.
    Choy, Edwin
    Marino-Enriquez, Adrian
    Morgan, Jeffrey A.
    Cote, Gregory M.
    Merriam, Priscilla
    Wagner, Andrew J.
    Sorger, Peter K.
    Santagata, Sandro
    George, Suzanne
    CLINICAL CANCER RESEARCH, 2024, 30 (07) : 1281 - 1292
  • [3] Phase II trial of cetuximab in patients (pts) with metastatic and/or locally advanced soft tissue and bone sarcomas
    Ha, H. T.
    Chugh, R.
    Griffith, K. A.
    Thomas, D. G.
    Schuetze, S. M.
    Lucas, D. R.
    Biermann, J. S.
    Zalupski, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A phase II study tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas
    Nye, Lauren Elizabeth
    Polish, Ariel
    Abbinanti, Susan E.
    Vintilescu, Claudia Rosana
    Rademaker, Alfred
    Humphreys, Catherine
    Cehlc, Raslma
    McFarland, Thomas
    Milhem, Mohammed M.
    Skubitz, Keith M.
    Van Tine, Brian Andrew
    Okuno, Scott H.
    Aguinik, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] A phase II trial of axitinib plus pembrolizumab for patients with advanced alveolar soft part sarcoma (ASPS) and other soft tissue sarcomas (STS).
    Wilky, Breelyn A.
    Trucco, Matteo Maria
    Kolonias, Despina
    Wieder, Eric
    Subhawong, Ty
    Rosenberg, Andrew
    Kwon, Deukwoo
    Park, Wungki
    Florou, Vaia
    Kerr, Darcy A.
    Sfakianaki, Efrosyni
    Merchan, Jaime R.
    Komanduri, Krishna
    Trent, Jonathan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas
    D'Adamo, DR
    Anderson, SE
    Albritton, K
    Yamada, J
    Riedel, E
    Scheu, K
    Schwartz, GK
    Chen, H
    Maki, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7135 - 7142
  • [7] A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas
    Agulnik, M.
    Costa, R. L. B.
    Milhem, M.
    Rademaker, A. W.
    Prunder, B. C.
    Daniels, D.
    Rhodes, B. T.
    Humphreys, C.
    Abbinanti, S.
    Nye, L.
    Cehic, R.
    Polish, A.
    Vintilescu, C.
    McFarland, T.
    Skubitz, K.
    Robinson, S.
    Okuno, S.
    Van Tine, B. A.
    ANNALS OF ONCOLOGY, 2017, 28 (01) : 121 - 127
  • [8] Elderly patients and metastatic soft tissue sarcomas (STS): a monoinstitutional experience
    Comandone, A.
    Boglione, A.
    Giubellino, E.
    Bergnolo, P.
    Dal Canton, O.
    Garetto, F.
    Ottaviani, D.
    Pochettino, P.
    Mele, T.
    Sartori, M. L.
    ANNALS OF ONCOLOGY, 2017, 28 : 56 - 56
  • [9] A phase II study of tivozanib in patients with metastatic and non-resectable soft tissue sarcomas
    Agulnik, Mark
    Milhem, Mohammed M.
    Rademaker, Alfred
    Humphreys, Catherine
    Abbinanti, Susan E.
    Nye, Lauren Elizabeth
    Cehic, Rasima
    Polish, Ariel
    Vintilescu, Claudia Roxana
    McFarland, Thomas
    Skubitz, Keith M.
    Robinson, Steven Ian
    Okuno, Scott H.
    Van Tine, Brian Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] A SARC multicenter phase III study of gemcitabine (G) vs. gemcitabine and docetaxel (G+D) in patients (pts) with metastatic soft tissue sarcomas (STS).
    Maki, R. G.
    Hensley, M. L.
    Wathen, J. K.
    Patel, S. R.
    Priebat, D. A.
    Okuno, S.
    Reinke, D.
    Thall, P. F.
    Benjamin, R. S.
    Baker, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 523S - 523S
12345